News in the Life Sciences Industry

GOTHENBURG, Sweden, Dec. 20, 2019 /PRNewswire/ -- Isofol Medical AB (publ), (Nasdaq First North Premier: ISOFOL). A patent covering the Active Pharmaceutical Ingredient (API), arfolitixorin hemisulfate, in Isofol's drug candidate has been approved by the the Japanense Patent Office. The Patent... Read more ››

STOCKHOLM, Dec. 20, 2019 /PRNewswire/ -- AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of drug candidates for diseases affecting the central nervous system, with a focus on Alzheimer's disease, announces that it has obtained the necessary... Read more ››

STOCKHOLM, Dec. 19, 2019 /PRNewswire/ -- IRRAS, a global healthcare company with a comprehensive portfolio of innovative products for neurocritical care, announced today that it received CE Mark approval for its IRRAflow(®) catheter. This CE Mark complements the two CE Marks previously... Read more ››

GOTHENBURG, Sweden, Dec. 19, 2019 /PRNewswire/ -- Getinge announces today an agreement to acquire 100% of the shares in Applikon Biotechnology B.V. from Applikon Biotechnology Holding B.V. Applikon Biotechnology B.V. is a leading company in the fast growing area of advanced bioreactor systems... Read more ››

STOCKHOLM, Dec. 19, 2019 /PRNewswire/ -- Calliditas Therapeutics AB (publ) ("Calliditas") today announced that 198 out of a total of 200 patients required for Part A of the Company's pivotal Phase 3 study NefIgArd, have been randomized. Top line readout of Part A of the study can thus be... Read more ››

LUND, Sweden, Dec. 18, 2019 /PRNewswire/ -- BioInvent International AB ("BioInvent" or the "Company") (OMXS: BINV) today announces that it has entered into a clinical trial collaboration and supply agreement with MSD, a tradename of Merck & Co., Inc., Kenilworth, NJ., USA, to evaluate the... Read more ››

STOCKHOLM, Dec. 18, 2019 /PRNewswire/ -- The press conference held in connection with the publication of Essity's Year-end Report for 2019 will also be available via webcast and it is possible to join by phone.

STOCKHOLM, Dec. 18, 2019 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR) today announces that the first patient has been enrolled and is being dosed with remetinostat gel 1% in an investigator-initiated phase II clinical study in patients with squamous cell carcinoma (SCC). This... Read more ››

STOCKHOLM, Dec. 17, 2019 /PRNewswire/ -- Calliditas Therapeutics AB (publ) ("Calliditas") today announced that a $5 million milestone payment from its partner Everest Medicines II Limited ("Everest Medicines") has been triggered as per the licensing agreement under which Everest is to develop... Read more ››

LUND, Sweden, Dec. 17, 2019 /PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX), today announced that the first patient has been successfully dosed in the Phase I study with the wholly owned 4-1BB antibody ATOR-1017, which is being developed for the treatment of metastasized... Read more ››

STOCKHOLM, Dec. 17, 2019 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today the initiation of a research collaboration with Eisai aimed at further studying the unique profile of the investigational drug candidate BAN2401.